Back to search
MGD-Meibomian Gland Dysfunction
Clinical trial pipeline · Data from ClinicalTrials.gov
See which MGD-Meibomian Gland Dysfunction trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which MGD-Meibomian Gland Dysfunction trials you may qualify forDry eye syndrome is a common eye disease that affects 1 to 2 out of 10 persons around the planet. One common cause of this disease is the meibomian gland dysfun…
The goal of this prospective, 24-week, double-masked, randomized, sham-controlled clinical trials to compare clinical efficacy and safety of RF and MGX with MGX…
The use of photobiomodulation or low-level light therapy (LLLT) in the ophthalmic field stemmed from dermatology which has shown impact on skin blood flow and r…
The purpose of this research study is to understand the mechanism of action of low level light therapy and also potentially yield markers associated with good t…
The goal of this clinical trial is to determine if there is a difference in eyelid temperature after low-level light therapy (LLLT) in individuals with differen…
Contrast sensitivity (CS) and tear film (TF) changes are noted in late postoperative period after upper blepharoplasty (UB), while the same was rarely investiga…
TearCare is an office-based thermal therapeutic eyelid technology cleared by the US Food and Drug Administration for the treatment of evaporative dry eye diseas…
This research study evaluates a prescription eye drop called Vevye® (cyclosporine 0.1%) for adults who have meibomian gland dysfunction (MGD), a common eye cond…
Dry eye disease (DED) is a common chronic condition characterized by ocular surface discomfort and tear film instability. Evaporative DED associated with meibom…